CARDIOPROTECTION IN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
https://doi.org/10.17802/2306-1278-2019-8-3-52-59
Abstract
Aim To evaluate cardioprotective effects of combined intracoronary phosphocreatine and succinic acid administration after primary percutaneous coronary intervention (PCI) in patients with ST elevation acute coronary syndrome who were present within 12 hours of symptom onset.
Methods Seven patients with STEMI presenting within 12 hours of onset of symptoms and thrombotic occlusion of the left anterior descending artery were included in the study. Evaluation of efficiency and safety was performed with the recording of major adverse cardiac events, evaluation of the procedure success, and the rate of composite endpoints.
Results Six (85.7%) patients after primary PCI showed TIMI grade 3 flow on control coronary angiography. None complications had been reported after intracoronary administration of phosphocreatine and succinic acid. Acquired left ventricular aneurysms were found in two patients in the in-hospital period. One patient was readmitted with acute coronary syndrome without ST-segment elevation. Coronary angiography reported restenosis of the previously implanted stent. No definite increase in the left ventricular ejection fraction had been found in the in-hospital and long-term period.
Conclusion There were no evidences on definite increase in myocardial contractility. The obtained results might partially be explained by the median symptom-to-balloon time over 400 minutes.
About the Authors
I. E. Vereshchagin
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
Vereshchagin Ivan E., research assistant at the Laboratory of Interventional Methods of Diagnosis and Treatment of Atherosclerosis
6, Sosnoviy Blvd., Kemerovo, 650002
V. I. Ganyukov
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
Ganyukov Vladimir I., PhD, Head of the Laboratory of Interventional Methods of Diagnosis and Treatment of Atherosclerosis
6, Sosnoviy Blvd., Kemerovo, 650002
I. N. Mamchur
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
Mamchur Irina N., researcher at the Laboratory of Ultrasound and Electrophysiological Methods of Diagnosis
6, Sosnoviy Blvd., Kemerovo, 650002
References
1. Go A.S., Mozaffarian D., Roger V.L. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1): e6-e245. doi: 10.1161/CIR.0b013e31828124ad
2. Bockeria L.A., Alekyan B.G. Endovascular diagnosis and treatment of the heart and blood vessels diseases in Russian Federation – 2015. Moscow: Nauchnyy tsentr serdechnososudistoi khirurgii imeni A.N. Bakuleva; 2016 [in Russian]
3. Ioseliani D.G., Filatov A.A., Rigan S.V. Vosstanovlenie krovotoka v infarct svyazannoy arterii pri ostrom infarkte miokarda: effectivno ili tolko effectno? Mezjdynarodnyi zjyrnal interventsionnoy kardioangiologii. 2003; 1: 33 [in Russian]
4. Kloner R.A., Ganote C.E., Jennings R.B. The no-reflow phenomenon after temporary coronary occlusion in the dog. J. J Clin Invest. 1974 Dec; 54(6): 1496–1508. doi: 10.1172/JCI107898
5. Shakhnovitc R.M. Optimizatsiya energeticheskogo metaboluzma u bolnych ishemicheskoi bolezny serdtsa. Russkii Meditsinskii Zjurnal. 2001;15: 622-628 [in Russian]
6. Eremenko A.A., Kolpakov P.E., Babaev M.A., Revunenkov G.V., Fominykh M.V. The use of levosimendan in cardiac surgery patients with chronic heart failure. Anesteziologiya i reanimatologiya. 2010; 2: 24–7. [in Russian]
7. Spasski A.A., Mikhaylov A.A., Kharitonov A.Y. Intracoronary administration of metabolic agents in the treatment of acute coronary syndrome. Kachestvennaya klinicheskaya praktika. 2017;(3):35-37. [in Russian]
8. Ioseliani D.G, Koledinskii A.G, Kushkina N.V, Lyagileva M.V, Semitko S.P, Aligisheva Z.A. Ogranichivaet li vnutrikoronarnaya terapiya metabolicheskimi tsitoprotektorami reperfuzionnoe povrezjdenie miokarda posle endovaskularnukh protsedur u patsientov s ostrum infarktom miokarda? Mezjdynarodnyi zjyrnal interventsionnoy kardioangiologii. 2008; 15: 32–41. [in Russian]
9. Kardioprotektsiya: fundamentalnue I klinicheskie aspektu. St. Petersburg; 2015. [in Russian]
10. Saks. V.A. Phosphokreatinovii put’ vnutrikletochnogo transporta energii: sovremennoe sostouanie voprosa. V kn.: Fosfokreatin: biohimicheskoe i farmakologicheskoe dejstvie i klinicheskoe primenenie. Pod red. V. A. Saksa, YU. G. Bobkova, E. Strumia. Moscow: Nauka; 2014. p. 9-16. [in Russian]
11. Lakomkin V.L., Novikova N.A., Shteinchneuder A.Ya. Neruchenie sokratitel’nou funktsii krus pri khronicheskom diphitsite phosphokreatina. V kn.: Fosfokreatin: biohimicheskoe i farmakologicheskoe dejstvie i klinicheskoe primenenie. Pod red. V. A. Saksa, YU. G. Bobkova, E. Strumia.Moscow: Nauka; 2014. p. 79-88. [in Russian]
12. Landoni G., Zangrillo A., Lomivorotov V.V., Likhvantsev V., Ma J., De Simone F., Fominskiy E. Cardiac protection with phosphocreatine: a meta-analysis. Interact. Cardiovasc. Thorac. Surg., 2016 Oct;23(4):637-46. doi: 10.1093/icvts/ivw171.
13. Dorovskikh V.A., Li O.N., Simonova N.V. Antioksidantnue svoystva preperatov na osnove yzntarnoi kislotu pri teplovom vozdeustvii na organism. Tikhookeanskii meditsinskii zjurnal. 201;, 2: 53-55 [in Russian]
14. Krebs H.A., Kornberg H.L., Burnon K. A survey of the energy transfor mations in living matter. Ergeb. Physiol. 1957; 49: 212–298. http://dx.doi.org/10.1007/BF02269485. PMID: 13609573
15. Truong Q.A., Cannon C.P., Zakai N.A., Rogers I.S., Giugliano R.P., Wiviott S.D., McCabe C.H., Morrow D.A., Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. . Am Heart J. 2009 Apr;157(4):673-679.e1. DOI:10.1016/j.ahj.2008.12.010.
16. Boyarintsev V.V, Zakaryan N.V, Ardashev V.N. Pervishnoe chreskozjnoe koronarnoe vmechatel’stvo pri infarkte miokarda. Yspechnosn’ I tenevue momentu. Lechenie I profilaktica. 2016;3(19): 10-16 [in Russian]
17. Spasskii A.A, Mikhailov A.A, Kharitonov A.U. Vnutrikoronarnoe vvedenie metabolicheskikh preparatov v lechenii ostrogo koronarnogo sindroma. Kachestvennaya klinicheskaya praktika. 2017; 3: 35-37 [in Russian]
18. Sergeeva E.A, Krytitskii S.S, Velikanova E.A. Diagnosticheskaya znachimost’ opticheskoi biopsii miokarda dlya otsenki vurazjennosti ichemicheskogo I reperfuzionnogo povrezjdeniya. Kompleksnie problem serdechno-sosudistich zabolevanii. 2016; 3: 10-15. [in Russian]
19. Wallimann T., Tokarska-Schlattner M., Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino acids. 2011; 40(5):1271-1296. doi: 10.1007/s00726011-0877-3.
20. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107-1213.
21. Ioseliani D.G, Koledinskii A.G, Kushkina N.V. Vozmozjno li ogranichenie reperfuzionnogo povrezjdenija kardiomiotsitov pri endovaskularnob vosstanovlenii krovotoka v infarktotvetstvennoi arterii putem vnutrikoronarnogo vvedeniya metabolicheskich tsitoprotectorov? Mezjdynarodnyi zjyrnal interventsionnoy kardioangiologii. 200; 11: 11-19 [in Russian]
22. Pereverzev D.I, Simonova N.V, Dorovskich V.A, Anokhina R.A. Vliyanie tsitoflavina na parametru sistolicheskoi fynktsii levogo jzelydoshka y bol’nuch ostrum infarktom miokarda. Eksperimental’naya I klinicheskay farmakologiya. 2017; 80 (1): 14-17 [in Russian]
23. Verechshagin I.E., Ganukov V.I., Sizova I.N., Verechshagin E.I. Kardioprotektsiya pri pervichnom chreskojznom koronarnom vmechatel’stve y patsienta s ostrum infarktom miokarda. Fundamental’naya I klinicheskaya meditsina. 2017; 4: 79-84. [in Russian]
Review
For citations:
Vereshchagin I.E., Ganyukov V.I., Mamchur I.N. CARDIOPROTECTION IN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION. Complex Issues of Cardiovascular Diseases. 2019;8(3):52-59. (In Russ.) https://doi.org/10.17802/2306-1278-2019-8-3-52-59
Views:
677
